Copy to clipboard 
The Private Equity fund of Gilde Healthcare acquired a majority stake in Chr. Diener.
Founded in 1900, Chr. Diener builds on a long heritage of surgical instrument making. Today, the company is known for designing and manufacturing customer-specific instruments for several international OEMs in orthopedic and spinal surgery. Located in Tuttlingen, Germany, Chr. Diener produces highly complex instruments with its staff of 90 workers.
Carolin and Michael Baur, Managing Directors of Chr. Diener, said they are proud of the company’s long history and of its strong position today.
“In the current dynamic market, we see several opportunities to further expand Chr. Diener’s position and are excited to partner with Gilde Healthcare in this journey,” they said. “With their many years of experience and international know-how in the healthcare and medical technology markets, we see Gilde as a great partner for the future.”
Gilde Healthcare will actively support the existing management of Chr. Diener to further build out its position in complex surgical instruments by investing in new capacity and services. With the support of Gilde Healthcare, the company plans to accelerate growth with both existing and new clients. Moreover, Gilde Healthcare sees a clear opportunity to build a market leading instrument manufacturing group, whereby Chr. Diener will serve as the first member of a larger group.
“We are pleased by the trust placed in us by Carolin and Michael, and look forward to working with them in the future,” Rafael Natanek, Partner, Private Equity fund of Gilde Healthcare, said. “Together, we see ample opportunities to further build out Chr. Diener’s strong market position. With ongoing consolidation in the instrument market, we also see an opportunity to do further acquisitions and build a larger instrument manufacturing group.
“With our investment in Chr. Diener, we have completed our fifth private equity investment in Germany, four of which closed in the past 18 months. This underpins the strength of our European healthcare network, our local presence in Germany and our ability to partner successfully with founders and families to help them further accelerate growth.”
